OpenFilings

Karyopharm Therapeutics Inc.

Form10-K

Report Period2022-12-31

Date Filed2023-02-17

Time Filed07:34:17

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.14
EX-10.20
EX-10.23
EX-10.25
EX-10.29
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
Filing on SEC Edgar